Acadia Pharmaceuticals | ACAD - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
ALKERMES USD 1.81B 57.02M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Cara Therapeutics USD 20.95M 6.92M 2025-12
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Cytokinetics USD -826.57M 166.94M 2026-03
Eisai JPY 906.56B 7.57B 2026-06
Eli Lilly USD 31.2B 4.66B 2026-03
Incyte USD 6.34B 721.58M 2026-06
J&J USD 84.97B 3.78B 2026-06
Moderna USD 6.76B 647M 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Pfizer USD 90.1B 3.63B 2026-03
Prothena USD 312.62M 32.14M 2026-03
PTC Therapeutics USD -165.36M 15.1M 2026-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03